[1] TISHA C. KING HEIDEN . Developmental toxicity of low generation PAMAM dendrimers in zebrafish[J]. Toxicology and applied pharmacology, 2007, 225 1: Pages 70-79. DOI:
10.1016/j.taap.2007.07.009[2] ASGHAR NARMANI Javad M Kamal Yavari. Imaging, biodistribution and in vitro study of smart 99mTc-PAMAM G4 dendrimer as novel nano-complex[J]. Colloids and Surfaces B: Biointerfaces, 2017, 159: Pages 232-240. DOI:
10.1016/j.colsurfb.2017.07.089[3] KATARZYNA MILOWSKA Teresa G Marta Malachowska. PAMAM G4 dendrimers affect the aggregation of α-synuclein[J]. International Journal of Biological Macromolecules, 2011, 48 5: Pages 742-746. DOI:
10.1016/j.ijbiomac.2011.02.021[4] BING WANG . Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers[J]. International Journal of Pharmaceutics, 2010, 395 1: Pages 298-308. DOI:
10.1016/j.ijpharm.2010.05.030[5] S. SADEKAR . Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin[J]. International Journal of Pharmaceutics, 2013, 456 1: Pages 175-185. DOI:
10.1016/j.ijpharm.2013.07.071